Opinion
From DMT vapes to MDMA gummies, psilocybin mushroom chocolate bars, and LSD microdots, an expanding range of psychedelic Consumer Packaged Goods (CPG) products is becoming increasingly available in the U.S. and Europe.
Thanks to organizing from local advocacy organizations, Minnesota has quietly become a hotbed of reform launching a psychedelic task force and deprioritized arrests related to entheogenic plants and fungi.
Bia Labate of the Chacruna Institute believes that it’s time to rethink psychedelic risk and end the prohibitionist mindset.
Michigan psychedelic advocates have scored local victories amidst battles to pass legislation for wider access to entheogenic plants.
When it comes to voting on psychedelics, there’s no messing with Texas. In this first column in the new series “The Psychedelic State(s) of America,” Noah Daly and Jack Gorsline explore the roots of Texas’ fast-moving psychedelic policy reform efforts, what the Texas Ibogaine Initiative aims to accomplish, and the future of psychedelic access in Texas beyond the scope of the state legislature.
The writer Erik Davis offers tactics for how to keep it together, navigate the weirdness, access creative capacity and respond to what the moment demands without losing our minds.
Paul Ryder returns to his ancestral homelands in the British Isles to connect with the spirits of the land and his warrior heritage.
A PhD candidate in clinical psychology, Josh Lipson, reflects on the perception of psychedelics after the FDA decision, their role in meaning-making and enchantment, and the importance of the sacred frame.
